Effect of transforming growth factor-β1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts

Otolaryngology - Head and Neck Surgery

Volumn 143, Issue 1, 2010, Pages 66-71

  Bran, Gregor M ^a   Goessler, Ulrich R ^a   Baftiri, Ariton ^a   Hormann, Karl ^a   Riedel, Frank ^a   Sadick, Haneen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1;

ANTISENSE THERAPY; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EAR RECONSTRUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KELOID; MONOLAYER CULTURE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT;

CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; CROSS-SECTIONAL STUDIES; FIBROBLASTS; HUMANS; KELOID; MATRIX METALLOPROTEINASES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OTOLOGIC SURGICAL PROCEDURES; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953669873     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2010.03.029     Document Type: Article

References (20)

1. Bran G.M., Goessler U.R., Hormann K., et al. Keloids: current concepts in pathogenesis. (review). Int J Mol Med 24 (2009) 283-293
2. Soo C., Shaw W.W., Zhang X., et al. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg 105 (2000) 638-647
3. Vaalamo M., Weckroth M., Puolakkainen P., et al. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 135 (1996) 52-59
4. Kähäri V.M., and Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 6 (1997) 199-213
5. Bock O., and Mrowietz U. Keloide-Eine dermale fibroproliferative Erkrankung unbekannter Ursache. Der Hautarzt 53 (2002) 515-523
6. Shah M., Foreman D.M., and Ferguson M.W. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 108 (1995) 985-1002
7. Ma C., Tarnuzzer R.W., and Chegini N. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells and their regulation by transforming growth factor-β1. Wound Repair Regen 7 (1999) 477-485
8. Bettinger D.A., Yager D.R., Diegelmann R.F., et al. The effect of TGF-β on keloid fibroblast proliferation and collagen synthesis. Plast Recon Surg 98 (1996) 827-833
9. Sadick H., Herberger A., Reidel K., et al. TGF-β1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts. Int J Mol Med 22 (2009) 55-60
10. Hernandez A., and Evers B.M. Functional genomics: clinical effect and the evolving role of the surgeon. Arch Surg 134 (1999) 1209-1215
11. Al-Attar A., Mess S., Thomassen J.M., et al. Keloid pathogenesis and treatment. Plast Reconstr Surg 117 (2006) 286-300
12. Slemp A.E., and Kirschner R.E. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 18 (2006) 396-402
13. Mustoe T.A., Cooter R.D., Gold M.H., et al. International clinical recommendations on scar management. Plast Reconstr Surg 110 (2002) 560-571
14. Niessen F.B., Spauwen P.H., Schalkwijk J., et al. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104 (1999) 1435-1458
15. Jagadeesan J., and Bayat A. Transforming growth factor (TGF-β) and keloid disease. Int J Surg 5 (2006) 278-285
16. Lee T.Y., Chin G.S., Kim W.J., et al. Expression of transforming growth factor β 1, 2 and 3 proteins in keloids. Ann Plast Surg 43 (1999) 179-183
17. Neely A.N., Clendening C.E., Gardener J., et al. Gelatinase activity in keloids and hypertrophic scars. Wound Repair Regen 7 (1999) 166-171
18. Fujiwara M., Muragaki Y., and Ooshima A. Keloid-derived fibroblasts show increased secretion of factors in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 153 (2005) 295-300
19. Uchida G., Yoshimura K., Kitano Y., et al. Tretinoin reverses up-regulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts. Exp Dermatol 12 (2003) 35-42
20. Imaizumi R., Akasaka Y., Inomata N., et al. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression on MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression. Histopathology 54 (2009) 722-730